Monsenso enables the remote collection of patient-
generated data and device-generated data from
clinical, post-approval to real-world studies.
Monsenso enables real-world evidence (RWE) generation through patient-generated & device-generated data collection across the product life cycle.
Enable patient-centred drug development with our solutions to impact outcomes that matter to patients. Our solutions are developed with and for patients with mental health and psychiatric conditions to reduce their burden of contributing to research.
Equip global, multi-centre, non-interventional, longitudinal studies with our solutions to measure safety and efficacy, describe patient, drug use, and clinical development across treatment pathways in real-world medical and clinical practice for regulators.
Engage patients with our solutions to enable personalised care, education, self-management, behavioral change, symptom and disease progression monitoring, and medication adherence. Demonstrate value to patients, prescribing physicians and payers.
Enhance the development and validation of digital endpoints, biomarkers, therapeutics, and pharmacogenomics testing in the real-world setting using our capabilities for continuous stream of active and passive patient data capture.